4Moving Biotech: Series ADeveloping disease-modifying osteoarthritis drug for knee osteoarthritisOct 4, 2026RoundOS4Moving BiotechCompany profile and funding historySourcesbusinesswire.comMore in BiotechAusperBio · Series CProFound Therapeutics · StrategicTransfyr · SeedBiotechFranceHealthtechEuropeSeries A